Blog

Oct 11, 2024, 17:15

The conundrum of CD8+T cells in low antigenic tumours – Cell Stress and Immunity (CSI) Lab

Cell Stress & Immunity (CSI) Lab shared a post on X:

“Happy to share this nice commentary by Angeliki Datsi (Rüdiger Sorg’s lab) on the conundrum of CD8+T cells in low antigenic tumours e.g., Glioblastoma & its impact on Cancer Immunotherapy!

Read here.”

The conundrum of CD8+T cells in low antigenic tumours - Cell Stress and Immunity (CSI) Lab

The conundrum of CD8⁺ T cell trajectories in low antigenic tumors: How to overcome a hypofunctional state distinct from antigen-driven exhaustion?

Authors: Angeliki Datsi, Rüdiger V. Sorg and Abhishek D. Garg.

The conundrum of CD8+T cells in low antigenic tumours - Cell Stress and Immunity (CSI) Lab

Abhishek D. Garg Angeliki Datsi antigenic tumours cancer cancer awareness cancer care cancer immunotherapy Cell Stress & Immunity (CSI) Lab Cell Stress and Immunity csi csi lab fight against cancer glioblastoma Global fight against cancer OncoDaily Oncology Rüdiger Sorg's lab Rüdiger V. Sorg

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage